Servier Affaires Médicales
Clinical trials sponsored by Servier Affaires Médicales, explained in plain language.
-
New combo pill aims to tame tough leukemia without harsh chemo
Disease control Recruiting nowThis study tests the safety of combining ivosidenib and azacitidine in adults newly diagnosed with a specific genetic form of acute myeloid leukemia (IDH1-mutated AML) who are not healthy enough for intensive chemotherapy. About 245 participants will receive the drug combination …
Phase: PHASE3 • Sponsor: Servier Affaires Médicales • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for bile duct cancer: targeted pill shows promise in Late-Stage trial
Disease control Recruiting nowThis study tests a daily pill called ivosidenib in 220 adults with advanced bile duct cancer that has a specific gene change (IDH1 mutation). Participants must have already tried at least one other cancer treatment. The goal is to confirm the drug is safe and helps control the ca…
Phase: PHASE3 • Sponsor: Servier Affaires Médicales • Aim: Disease control
Last updated May 18, 2026 12:02 UTC